Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.600
+0.005 (0.31%)
Nov 11, 2026, 11:57 AM EST - Market open

BDTX Stock Forecast

BDTX's stock price has decreased by -62.04% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 8 analysts polled by S&P Global, BDTX stock has a consensus rating of "Buy" and an average price target of $10.86. The average 1-year stock price forecast is 578.75% higher than the current stock price, while the lowest is $8.00 (+400.00%) and the highest is $14 (+775.00%).

Price Target: $10.86 (+578.75%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$8.00$10.86$11$14
Change+400.00%+578.75%+587.50%+775.00%

Analyst Ratings

The average analyst rating for BDTX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Aug '26Oct '26
Strong Buy666655
Buy222222
Hold111111
Sell000000
Strong Sell000000
Total999988

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$11
BuyReiterates$11+587.50%Nov 10, 2026
Raymond James
Raymond James
Buy
Maintains
$11
BuyMaintains$11+587.50%Aug 6, 2026
Jefferies
Jefferies
Buy
Maintains
$10
BuyMaintains$10+525.00%Aug 6, 2026
Wedbush
Wedbush
Buy
Reiterates
$14
BuyReiterates$14+775.00%Aug 6, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$8
BuyMaintains$8+400.00%Aug 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
7.14M
from 70.00M
Decreased by -89.80%
Revenue Next Year
n/a
from 7.14M
Decreased by -100.00%
EPS This Year
-0.72
from 0.52
EPS Next Year
-1.11
from -0.72
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
----70.00M7.14M
Revenue Growth
------89.80%
Gross Profit
----70.00M6.43M
Gross Margin
----100.00%90.00%
Operating Income
-126.87M-92.83M-86.46M-78.78M19.87M-49.72M
Net Income
-125.60M-91.17M-82.44M-69.68M22.37M-42.96M
EPS
----0.52-0.72
Free Cash Flow
----29.61M-44.00M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High50.0M
Avg7.1M
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-28.6%
Avg
-89.8%
Low
-100.0%

EPS Forecast

EPS202620272028
High-0.68
Avg-0.72
Low-0.75

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-